Back
Cyclacel Pharmaceuticals Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Sell
23
CYCC
Cyclacel Pharmaceuticals
Last Price:
1.00
Seasonality Move:
-12.83%
Sell
18
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
21.00
Seasonality Move:
-9.84%
Sell
23
Cyclacel Pharmaceuticals (CYCC)
is a Sell
Is Cyclacel Pharmaceuticals a Buy, Sell or Hold?
- The current Cyclacel Pharmaceuticals [CYCC] share price is $1.00. The Score for CYCC is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- CYCC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Corbus Pharmaceuticals Holdings (CRBP)
is a Sell
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $21.51. The Score for CRBP is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- CRBP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CYCC Stock Price Chart
What is Cyclacel Pharmaceuticals's stock price today?
-
The Cyclacel Pharmaceuticals share price today is $1.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYCC is experiencing selling pressure, which indicates risk of future bearish movement.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $21.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBP is experiencing slight selling pressure.
CYCC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 35.2 | Sell |
Chaikin Money Flow: | -35462 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.01 - 1.13) | Sell |
Bollinger Bands (100): | (1.18 - 2.04) | Sell |
CRBP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -8.8 | Sell |
Relative Strength Index (14 RSI): | 26.98 | Sell |
Chaikin Money Flow: | -481436 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.56 - 62.22) | Sell |
Bollinger Bands (100): | (40.36 - 58.28) | Sell |
CYCC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.01 | Sell |
20-day SMA: | 1.04 | Sell |
50-day SMA: | 1.29 | Sell |
200-day SMA: | 2.03 | Sell |
8-day EMA: | 1.02 | Sell |
20-day EMA: | 1.07 | Sell |
50-day EMA: | 1.26 | Sell |
200-day EMA: | 2.75 | Sell |
CRBP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.47 | Sell |
20-day SMA: | 45.29 | Sell |
50-day SMA: | 51.84 | Sell |
200-day SMA: | 37.33 | Sell |
8-day EMA: | 29.4 | Sell |
20-day EMA: | 40.5 | Sell |
50-day EMA: | 47.43 | Sell |
200-day EMA: | 38.91 | Sell |
Cyclacel Pharmaceuticals Earnings Growth & CYCC Earnings Dates
- Analysts estimate an earnings increase this quarter of $5.09 per share, an increase next quarter of $0.03 per share, an increase this year of $24.87 per share, and an increase next year of $0.73 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.11 per share, a decrease next quarter of $0.64 per share, an increase this year of $6.97 per share, and a decrease next year of $0.83 per share.
Cyclacel Pharmaceuticals Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corbus Pharmaceuticals Holdings Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |